Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode

NCT03646058 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.

NCT NCT03646058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03646058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Phase
Phase 3
Overall status
Recruiting
Start date
October 10, 2021
Completion date
January 31, 2027
Enrollment
180 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive episode, suicidal ideation